For the Inventor, By the Inventor

Enter inventor name

Danville, CA, United States of America

John M Nuss

USPTO Granted Patents = 54 (Patent Applications = 32)

CIPO Patents = 6 (Patent Applications = 8)

EPO Patents = 23 (Patent Applications = 30)

Average Co-Inventor Count = 5.6

ph-index = 17

Forward Citations = 801(Granted Patents)

Forward Citations (Not Self Cited) = 775(Dec 10, 2025)

Location History:

San Diego, CA (US) (2020)
Danville, CA (US) (1999 - 2021)
Carlsbad, CA (US) (2021)
Encinitas, CA (US) (2021 - 2023)

Company Filing History:

Chiron Corporation

Symphony Evolution, Inc.

Escalier Biosciences B.v.

Zomagen Biosciences Ltd

6. 2 out of 245

Novartis Vaccines & Diagnostics, Gmbh

Vimalan Biosciences, Inc.

Ventyx Biosciences, Inc.

10. 1 out of 3,923

Oppilan Pharma Ltd.

12. 1 out of 441

Daiichi Sankyo Company, Limited

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

NLRP3 Modulators

TYK2 Pseudokinase Ligands

JAK Inhibitors

ROR-Gamma Modulators

c-Met Modulators

Phosphatidylinositol 3-Kinase Inhibitors

Glycogen Synthase Kinase 3 Inhibitors

Anaplastic Lymphoma Kinase Modulators

Serine-Threonine Kinase Modulators

Pyrimidine Derivatives

Small Molecule Inhibitors

Heterocyclic Compounds

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466800 - N-((1,2,3,5,6,7-hexahydro-S-indacen-4-yl)carbamoyl)-4, 5, 6, 7-tetrahydrobenzofuran-2-sulfonamide derivatives and related compounds as NLPR3 modulators for the treatment of multiple sclerosis (MS) (2025-11-11),

2. 12351564 - NLRP3 modulators (2025-07-08),

3. 11780842 - TYK2 pseudokinase ligands (2023-10-10),

4. 11753411 - Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligands (2023-09-12),

5. 11603375 - NLRP3 modulators (2023-03-14),

6. 11459333 - Substituted pyrrolo[2,3-d]pyrimidines as JAK inhibitors (2022-10-04),

7. 11242350 - Spirocyclic ROR-gamma modulators (2022-02-08),

8. 11230555 - Bicyclic RORγ modulators (2022-01-25),

9. 11136329 - JAK inhibitors (2021-10-05),

10. 11124482 - C-met modulators and methods of use (2021-09-21),

11. 10905687 - Substituted piperazines as ROR-gamma modulators (2021-02-02),

12. 10683291 - Heterocyclic compounds for the treatment of disease (2020-06-16),

13. 9174947 - c-Met modulators and methods of use (2015-11-03),

14. 8889664 - Phosphatidylinositol 3-kinase inhibitors and methods of their use (2014-11-18),

15. 8791102 - Acetanilide sphingosine-1-phosphate receptor antagonists (2014-07-29),

Title: The Inventor John M Nuss: Pioneering Innovations in Danville, CA

Introduction: John M Nuss is a distinguished inventor based in Danville, CA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: John M Nuss holds several patents in the areas of technology, healthcare, and sustainability, showcasing his versatility and forward-thinking approach to problem-solving.

Career Highlights: With a career spanning over two decades, John M Nuss has established himself as a visionary inventor, with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of conventional thinking.

Collaborations: Throughout his career, John M Nuss has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and excellence in the industry.

Conclusion: John M Nuss's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor, shaping the future of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…